Pilot Study of GLY-LOW Supplementation in Postmenopausal Women With Obesity

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

July 27, 2023

Primary Completion Date

May 31, 2024

Study Completion Date

May 31, 2024

Conditions
Insulin ResistanceObesityCardiovascular DiseasesCognitive ImpairmentPhysical DisabilityDepressionInflammationHormone DeficiencyPhysical InactivityHyperlipidemiasHypertensionOvereating
Interventions
BIOLOGICAL

GLY-LOW

This supplement is available for over-the-counter purchase. Each capsule is a combination of vitamins and natural products: Vitamin B1 (100mg); Vitamin B6 (50mg); Niacin (200mg); Alpha Lipoic Acid (150mg); and Piperine (15mg). The supplement, GLY-LOW, is FDA approved for use as a dietary supplement (IND 162006)

Trial Locations (1)

82718

Hoskinson Health and Wellness Clinic, Gillette

Sponsors
All Listed Sponsors
collaborator

Buck Institute for Research on Aging

OTHER

collaborator

University of Wyoming

OTHER

lead

Hoskinson Health and Wellness Clinic

INDUSTRY